Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.

Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ, Chae JJ, Ettinger R, de Koning HD, Cruz AC, Kastner DL, Komarow H, Siegel RM.

Proc Natl Acad Sci U S A. 2010 May 25;107(21):9801-6. doi: 10.1073/pnas.0914118107.

2.

Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion.

Turner MD, Chaudhry A, Nedjai B.

Biosci Rep. 2012 Apr 1;32(2):105-12. doi: 10.1042/BSR20110089. Review.

3.

Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome.

Fairclough LC, Stoop AA, Negm OH, Radford PM, Tighe PJ, Todd I.

Eur J Immunol. 2015 Oct;45(10):2937-44. doi: 10.1002/eji.201545769.

4.

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).

Negm OH, Mannsperger HA, McDermott EM, Drewe E, Powell RJ, Todd I, Fairclough LC, Tighe PJ.

Eur J Immunol. 2014 Jul;44(7):2096-110. doi: 10.1002/eji.201344328.

5.

Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).

Bachetti T, Chiesa S, Castagnola P, Bani D, Di Zanni E, Omenetti A, D'Osualdo A, Fraldi A, Ballabio A, Ravazzolo R, Martini A, Gattorno M, Ceccherini I.

Ann Rheum Dis. 2013 Jun;72(6):1044-52. doi: 10.1136/annrheumdis-2012-201952.

PMID:
23117241
6.

Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).

Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, Kastner DL, Screaton GR, Siegel RM.

Blood. 2006 Aug 15;108(4):1320-7.

7.

Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.

Jéru I, Charmion S, Cochet E, Copin B, Duquesnoy P, Garcia MT, Le Borgne G, Cathebras P, Gaillat J, Karabina S, Dodé C, Lohse P, Hentgen V, Amselem S.

PLoS One. 2013 Jul 24;8(7):e69757. doi: 10.1371/journal.pone.0069757.

8.

Setting up TRAPS.

Pettersson T, Kantonen J, Matikainen S, Repo H.

Ann Med. 2012 Mar;44(2):109-18. doi: 10.3109/07853890.2010.548399. Review.

PMID:
21284532
9.

Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome.

Dickie LJ, Aziz AM, Savic S, Lucherini OM, Cantarini L, Geiler J, Wong CH, Coughlan R, Lane T, Lachmann HJ, Hawkins PN, Robinson PA, Emery P, McGonagle D, McDermott MF.

Ann Rheum Dis. 2012 Dec;71(12):2035-43. doi: 10.1136/annrheumdis-2011-201197.

PMID:
22679299
10.

A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family.

Dodé C, Papo T, Fieschi C, Pêcheux C, Dion E, Picard F, Godeau P, Bienvenu J, Piette JC, Delpech M, Grateau G.

Arthritis Rheum. 2000 Jul;43(7):1535-42.

11.

Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).

Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, Sack MN, Kastner DL, Siegel RM.

J Exp Med. 2011 Mar 14;208(3):519-33. doi: 10.1084/jem.20102049.

12.

Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene.

Rittore C, Sanchez E, Soler S, Barat-Houari M, Albers M, Obici L, McDermott MF, Touitou I, Grandemange S.

Ann Rheum Dis. 2014 Jan;73(1):290-7. doi: 10.1136/annrheumdis-2012-203023.

PMID:
23505244
13.

Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases.

Bachetti T, Ceccherini I.

J Mol Med (Berl). 2014 Jun;92(6):583-94. doi: 10.1007/s00109-014-1150-5. Review.

PMID:
24706103
14.

Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.

Todd I, Radford PM, Draper-Morgan KA, McIntosh R, Bainbridge S, Dickinson P, Jamhawi L, Sansaridis M, Huggins ML, Tighe PJ, Powell RJ.

Immunology. 2004 Sep;113(1):65-79.

15.

Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.

Rebelo SL, Amel-Kashipaz MR, Radford PM, Bainbridge SE, Fiets R, Fang J, McDermott EM, Powell RJ, Todd I, Tighe PJ.

Arthritis Rheum. 2009 Jan;60(1):269-80. doi: 10.1002/art.24147.

16.
17.

Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.

Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R.

Autoimmun Rev. 2012 Nov;12(1):38-43. doi: 10.1016/j.autrev.2012.07.020. Review.

PMID:
22884554
19.

Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients.

Nedjai B, Hitman GA, Church LD, Minden K, Whiteford ML, McKee S, Stjernberg S, Pettersson T, Ranki A, Hawkins PN, Arkwright PD, McDermott MF, Turner MD.

Cell Immunol. 2011;268(2):55-9. doi: 10.1016/j.cellimm.2011.02.007.

PMID:
21420073
20.
Items per page

Supplemental Content

Support Center